FDA Inspection 1026806 — NAMSA

NAMSA — FEI 3004495705

The FDA completed an inspection of NAMSA on September 15, 2017 in Chasse-Sur-Rhone. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 15, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Chasse-Sur-Rhone (France)